BOK Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $365K | Sell |
|
|||||
|
2025
Q2 | $328K | Sell |
|
|||||
|
2025
Q1 | $699K | Buy |
|
|||||
|
2024
Q4 | $568K | Buy |
|
|||||
|
2024
Q3 | $450K | Buy |
|
|||||
|
2024
Q2 | $552K | Sell |
|
|||||
|
2024
Q1 | $570K | Buy |
|
|||||
|
2023
Q4 | $528K | Buy |
|
|||||
|
2023
Q3 | $441K | Sell |
|
|||||
|
2023
Q2 | $419K | Sell |
|
|||||
|
2023
Q1 | $475K | Sell |
|
|||||
|
2022
Q4 | $604K | Buy |
|
|||||
|
2022
Q3 | $509K | Sell |
|
|||||
|
2022
Q2 | $475K | Buy |
|
|||||
|
2022
Q1 | $450K | Buy |
|
|||||
|
2021
Q4 | $395K | Sell |
|
|||||
|
2021
Q3 | $527K | Buy |
|
|||||
|
2021
Q1 | $1.97M | Buy |
|
|||||
|
2020
Q4 | $1.81M | Sell |
|
|||||
|
2020
Q3 | $1.92M | Buy |
|
|||||
|
2020
Q2 | $2.31M | Sell |
|
|||||
|
2020
Q1 | $1.73M | Buy |
|
|||||
|
2019
Q4 | $1.84M | Sell |
|
|||||
|
2019
Q3 | $1.6M | Sell |
|
|||||
|
2019
Q2 | $1.52M | Buy |
|
|||||
|
2019
Q1 | $489K | Sell |
|
|||||
|
2018
Q4 | $1.12M | Buy |
|
|||||
|
2018
Q3 | $1.38M | Buy |
|
|||||
|
2018
Q2 | $653K | Buy |
|